Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JEF
JEF logo

JEF Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
48.290
Open
47.710
VWAP
47.70
Vol
1.79M
Mkt Cap
9.72B
Low
47.240
Amount
85.57M
EV/EBITDA(TTM)
28.34
Total Shares
204.43M
EV
32.82B
EV/OCF(TTM)
--
P/S(TTM)
1.00
Jefferies Financial Group Inc. is a global investment banking and capital markets company. The Company's segments include Investment Banking and Capital Markets and Asset Management. The Investment Banking and Capital Markets segment includes its capital markets activities and its investment banking business, which provides underwriting and financial advisory services to its clients. It operates in the Americas; Europe and the Middle East; and Asia-Pacific. The Investment Banking and Capital Markets segment provides the sales, trading, origination and advisory effort for various fixed income, equity and advisory products and services. The Asset Management segment provides alternative investment management services to investors globally and generates investment income from capital invested in and managed by it or its affiliated asset managers and includes certain remaining businesses and assets of its legacy merchant banking portfolio.
Show More

Events Timeline

(ET)
2026-03-26
16:30:00
Major Averages Decline Amid Rising Oil Prices
select
2026-03-26
12:10:00
Major Averages Decline Amid Rising Oil Prices
select
2026-03-25 (ET)
2026-03-25
16:30:00
First Brands Reports Q1 Revenue of $2.02B
select
2026-03-24 (ET)
2026-03-24
09:00:00
U.S. Stock Futures Slightly Lower, Market Sentiment Cautious
select

News

Yahoo Finance
2.0
04-18Yahoo Finance
Jefferies Financial Group Shares Rise 3.3% Amid Middle East Ceasefire
  • Stock Price Surge: Jefferies Financial Group's shares rose 3.3% to $48.10 following the ceasefire in the Middle East, reflecting market optimism about the rebound in global equity prices and asset valuations, which directly boosts the company's assets under management and associated fee revenue.
  • Return to Risk Assets: The de-escalation in the Middle East encourages retail and institutional investors to rotate back into riskier assets, which is expected to drive revenue growth in investment banking and brokerage divisions, particularly in corporate M&A and advisory activities, creating a potential 'deal-making spring'.
  • Market Volatility: Jefferies' stock has experienced 16 moves greater than 5% over the past year; while today's increase is seen as significant, it indicates that the market's fundamental perception of the business remains unchanged, reflecting cautious optimism among investors regarding future prospects.
  • Long-Term Investment Returns: Despite a 23.8% decline in Jefferies' stock price year-to-date, investors who purchased $1,000 worth of shares five years ago would now see their investment grow to $1,479, indicating the company's long-term attractiveness, especially in a stable economic environment.
NASDAQ.COM
2.0
04-18NASDAQ.COM
Teva's FDA Approval of Long-Acting Drug Could Be Major Catalyst
  • New Drug Approval Outlook: Teva's New Drug Application for long-acting schizophrenia drug olanzapine has been accepted by the FDA, and if approved, it is expected to significantly enhance patient adherence, driving sales growth and becoming the company's most meaningful catalyst.
  • Specialty Drug Sales Surge: Teva's Austedo generated $2.26 billion in sales in 2025, marking a 34% year-over-year increase, with expectations to reach between $2.4 billion and $2.55 billion in 2026, showcasing strong momentum in the specialty drug sector.
  • Biosimilar Market Expansion: Teva plans to launch six new biosimilars in 2026 and 2027, potentially competing with Amgen and Johnson & Johnson, which will further solidify its position as the second-largest player in the biosimilar market.
  • Investor Confidence Boost: Analysts are optimistic about Teva's future, with 12 out of 15 analysts rating the stock as a
Fool
8.5
04-18Fool
Teva Pharmaceutical Shares Surge 130% with Optimistic Outlook
  • FDA Approval Catalyst: Teva's long-acting olanzapine injectable suspension NDA has been accepted by the FDA, with a decision expected later this year; approval could significantly enhance patient adherence, with combined annual sales with Uzedy projected to exceed $2 billion.
  • Specialty Drug Sales Surge: Teva's specialty drug Austedo generated $2.26 billion in sales in 2025, a 34% year-over-year increase, with expectations for 2026 sales to rise between $2.4 billion and $2.55 billion, reflecting strong market demand and competitive positioning in the specialty drug sector.
  • Biosimilar Expansion: Teva plans to launch six new biosimilars in 2026 and 2027, further solidifying its position as the second-largest player in the biosimilar market, with anticipated competition against giants like Amgen and Johnson & Johnson, driving future revenue growth.
  • Market Risk Factors: Despite several catalysts propelling stock price growth, a market crash or significant pipeline issues could derail Teva's momentum; however, the company's pipeline is relatively de-risked, and with a forward P/E of only 11.7, it presents a compelling value investment opportunity.
Globenewswire
7.0
04-14Globenewswire
Jefferies Financial Group Under Investigation for Securities Fraud
  • Securities Fraud Investigation: Pomerantz LLP is investigating whether Jefferies Financial Group and its executives engaged in securities fraud or other unlawful business practices, potentially leading to significant losses for investors.
  • Bankruptcy Fallout: Jefferies faces approximately $715 million in debt risk due to its ties with the bankrupt auto parts manufacturer First Brands, resulting in a 7.88% drop in its stock price on October 8, 2025.
  • Regulatory Scrutiny: The U.S. Securities and Exchange Commission is investigating whether Jefferies provided sufficient information to investors in its Point Bonita fund, raising further concerns about its transparency in the market.
  • Increased Litigation Risk: Western Alliance Bancorp is suing Jefferies, alleging that it failed to fulfill commitments on a large commercial loan, causing its stock price to plummet by 13.53% on March 6, 2026.
Yahoo Finance
6.0
04-13Yahoo Finance
Credo Technology Group Surges 10% on Buy Rating from Jefferies
  • Rating Upgrade: Jefferies initiated coverage of Credo Technology Group with a Buy rating and a $175 price target, leading to a more than 10% surge in stock price on Monday, reflecting market confidence in its future growth potential.
  • Market Outlook: Analysts noted that as AI-related data center demand expands, Credo's stock may not fully reflect the company's growth prospects, indicating investor interest in its long-term value.
  • Product Line Strength: Credo's active electrical cables (AECs) are expected to continue benefiting from data center buildouts tied to artificial intelligence and general-purpose computing, further solidifying its competitive position in the market.
  • New Revenue Stream: The company's entry into optical transceivers through ZeroFlap Optics is seen as a significant new revenue source, despite concerns about copper's relevance and co-packaged optics (CPO) being considered overstated by analysts.
Yahoo Finance
2.0
04-13Yahoo Finance
Credo Technology Shares Surge 10.3% After Buy Rating from Jefferies
  • Rating Upgrade: Jefferies initiated coverage on Credo Technology (NASDAQ:CRDO) with a Buy rating and a $175 price target, indicating a 46% upside, reflecting the market's undervaluation of its role in AI data center buildouts.
  • Stock Volatility: Despite a 250% increase in the stock price over the past twelve months, CRDO has experienced volatility, with analyst Blayne Curtis highlighting a valuation disconnect in the market, particularly regarding cable technology competition.
  • Future Revenue Potential: Jefferies estimates that Credo's ZeroFlap Optics could represent an annual revenue opportunity exceeding $300 million, with Oracle alone projected to contribute $225 million by 2027, indicating strong market demand.
  • Overblown Market Concerns: Curtis argues that fears surrounding the
Wall Street analysts forecast JEF stock price to rise
5 Analyst Rating
Wall Street analysts forecast JEF stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
55.00
Averages
72.79
High
97.00
Current: 0.000
sliders
Low
55.00
Averages
72.79
High
97.00
Goldman Sachs
NULL -> Buy
maintain
$47 -> $54
AI Analysis
2026-04-14
Reason
Goldman Sachs
Price Target
$47 -> $54
AI Analysis
2026-04-14
maintain
NULL -> Buy
Reason
Goldman Sachs raised the firm's price target on Jefferies Financial to $54 from $47 and keeps a Buy rating on the shares. Earnings estimates and price targets for investment banks were modestly adjusted based on final Dealogic data, reflecting slight increases in M&A and debt capital markets activity with equity capital markets unchanged, the analyst tells investors in a research note.
Morgan Stanley
Equal Weight
maintain
$49 -> $44
2026-03-26
Reason
Morgan Stanley
Price Target
$49 -> $44
2026-03-26
maintain
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Jefferies Financial to $44 from $49 and keeps an Equal Weight rating on the shares. The stock "needed a clear beat" to remove the overhang from macro-driven and credit/legal risks, says the analyst, who believes the "noisy quarter" is unlikely to shift positioning.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JEF
Unlock Now

Valuation Metrics

The current forward P/E ratio for Jefferies Financial Group Inc (JEF.N) is 12.82, compared to its 5-year average forward P/E of 14.85. For a more detailed relative valuation and DCF analysis to assess Jefferies Financial Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
14.85
Current PE
12.82
Overvalued PE
20.51
Undervalued PE
9.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
31.66
Current EV/EBITDA
20.99
Overvalued EV/EBITDA
56.14
Undervalued EV/EBITDA
7.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.45
Current PS
1.06
Overvalued PS
1.69
Undervalued PS
1.22

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Find me bearish stock to trade shorts on
Intellectia · 14 candidates
Market Cap: >= 3.00BRelative Vol: >= 1.30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Month Price Change Pct: <= $-20.00Monthly Average Dollar Volume: >= 1,500,000
Ticker
Name
Market Cap$
top bottom
EL logo
EL
Estee Lauder Companies Inc
25.86B
SMCI logo
SMCI
Super Micro Computer Inc
13.32B
WING logo
WING
Wingstop Inc
4.73B
MMYT logo
MMYT
MakeMyTrip Ltd
3.79B
CELH logo
CELH
Celsius Holdings Inc
9.52B
HSAI logo
HSAI
Hesai Group
3.18B
current bullish rsi divergences
Intellectia · 213 candidates
Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
NVO logo
NVO
Novo Nordisk A/S
170.38B
MELI logo
MELI
MercadoLibre Inc
89.62B
NTES logo
NTES
NetEase Inc
73.21B
ET logo
ET
Energy Transfer LP
63.96B
BIDU logo
BIDU
Baidu Inc
45.60B
TCOM logo
TCOM
Trip.com Group Ltd
35.00B

Whales Holding JEF

M
Migdal Mutual Funds Ltd.
Holding
JEF
+10.76%
3M Return
A
Allspring Global Investments, LLC
Holding
JEF
+9.79%
3M Return
P
Private Management Group Inc
Holding
JEF
+8.36%
3M Return
A
ACR Alpine Capital Research, LLC
Holding
JEF
+6.39%
3M Return
M
Munro Partners
Holding
JEF
+5.73%
3M Return
A
Alyeska Investment Group, L.P.
Holding
JEF
+5.49%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Jefferies Financial Group Inc (JEF) stock price today?

The current price of JEF is 47.57 USD — it has decreased -1.08

What is Jefferies Financial Group Inc (JEF)'s business?

Jefferies Financial Group Inc. is a global investment banking and capital markets company. The Company's segments include Investment Banking and Capital Markets and Asset Management. The Investment Banking and Capital Markets segment includes its capital markets activities and its investment banking business, which provides underwriting and financial advisory services to its clients. It operates in the Americas; Europe and the Middle East; and Asia-Pacific. The Investment Banking and Capital Markets segment provides the sales, trading, origination and advisory effort for various fixed income, equity and advisory products and services. The Asset Management segment provides alternative investment management services to investors globally and generates investment income from capital invested in and managed by it or its affiliated asset managers and includes certain remaining businesses and assets of its legacy merchant banking portfolio.

What is the price predicton of JEF Stock?

Wall Street analysts forecast JEF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JEF is72.79 USD with a low forecast of 55.00 USD and a high forecast of 97.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Jefferies Financial Group Inc (JEF)'s revenue for the last quarter?

Jefferies Financial Group Inc revenue for the last quarter amounts to 2.74B USD, increased 15.85

What is Jefferies Financial Group Inc (JEF)'s earnings per share (EPS) for the last quarter?

Jefferies Financial Group Inc. EPS for the last quarter amounts to 0.70 USD, increased 22.81

How many employees does Jefferies Financial Group Inc (JEF). have?

Jefferies Financial Group Inc (JEF) has 7787 emplpoyees as of April 21 2026.

What is Jefferies Financial Group Inc (JEF) market cap?

Today JEF has the market capitalization of 9.72B USD.